There is one Phase I trial registered as NCT02637284 in 2015, intended to enrol forty-two participants, which was subsequently cancelled with no published results [7]
Dosage & Administration Subcutaneous injection only
That difference usually comes from factors such as cell quality, internal resistance, pack age, temperature, and the overall honesty of the brands discharge claims
The oral form is often chosen for gut-related goals, on the rationale that it acts on the GI lining as it passes through the digestive tract though this rationale comes from animal research, and BPC-157 has not been shown in human trials to treat any specific gastrointestinal condition
Specifically, prolonged inhibition of KGDHC in both neuroblastoma cells and primary neurons has been shown to enhance the calcium response to potassium-induced depolarization by approximately 2843% following 24 to 48 h of treatment (Gibson et al., 2012)